CVR - Asthma and respiratory immunology Flashcards
What are the cardinal features of asthma?
- Wheeze/dry cough
- Atopy/allergen sensitisation
- Reversible airflow obstruction
- Airway inflammation
Describe the pathogenesis of asthma
- Normal airway smooth muscle is exposed to an allergen
- This results in the recruitment of inflammatory cells - mainly eosinophils
- As well as this the epithelium undergoes a structural change and the amount of matrix increases
- This inflammation and increases size of matrix and endothelium results in an inflamed airway
What must be present for a patient to develop asthma?
An underlying genetic succeptibility
Describe the mechanism of type 2 immunity in allergic asthma
- Antigen presented to dendritic cell
- The APC then, on MHC class II, takes the antigen to the thymus where the naive T cells are
- These T cells then differentiate in Th2 cells
- The Th2 cells contain IL-4, IL-5, IL-13 which cause the manifestations of asthma
What molecule causes the recruitment of the eosinophils to the airways?
IL-5
What effect does IL-4 cause?
- IL-4 causes B cells to release IgE
- When a person is exposed to the allergen again, the IgE activates mast cells
- The activation of these results in degranulation of the mast cell and then allergic asthma
How are allergies tested for?
Skin test:
- Intradermal injections
- Saline and histamine used as negative and positive test
- The allergens are then injected and compared to the controls
Blood test:
- Test for specific IgE antibodies to allergens of interest
- However TOTAL IgE not sufficient to define atopy
How do you test for asthma?
- Blood eosinophil count - If raised at normal health, indicative of asthma
- Induced sputum eosinophil count
- Exhaled nitric oxide - high is indicative, PROVIDED NOT ON STEROIDS
What are the tests done clinically for asthma?
- Airway obstruction on spirometry
- Reversible airway obstruction
- Exhaled nitric oxide
What treatments can be given to patients with asthma?
- Reduce airway eosinophilic inflammation:
- Inhaled corticosteroid
- Leukotriene receptor agonists
- Acute Symptomatic relief:
- Beta-2 agonists (smooth muscle relaxation)
- Anticholinergic therapies (smooth muscle relaxation)
- Severe asthma - steroid sparing therapies:
- Biologic targeted to IgE
- Anti-IgE antibody
- Biologics targeted to airway eosinophils
- Anti-interleukin-5 antibody
- Anti-interleukin-5 receptor antibody
- Biologic targeted to IgE
What do inhaled corticosteroids do?
- Reduce eosinophil level via inducing apoptosis
- Recuce type 2 mediators released by the Th2 cells
- Reduce mast cell numbers
Describe asthma management
- Provide patient with the optimal device
- Teach them the proper technique of using an inhaler
- Give the patient a clear asthma management plan for when they are healthy or feeling unwell
- Make sure the patient knows they must adhere to the inhaled corticosteroids, even when they are feeling well
What can cause an asthma attack?
Exposure to: - Allergens - Pathogens - Pollution and potentially a sudden exposure to a chemical, e.g. tobacco smoke
All have to happen
What is anti-IgE antibody therapy?
- Humanised anti-IgE monoclonal antibodies bind and capture circulation IgE - prevents interaction with mast cells and basophils to stop allergic cascade
- IgE production can be reduced after prolonged doses
- However if treatment is stopped, symptoms and asthma come back with time
What is mepolizumab?
It is a anti-IL-5 antibody